The Role of PML in the Nervous System (original) (raw)

• Grimwade D, Solomon E (1997) Characterisation of the PML/RAR alpha rearrangement associated with t(15;17) acute promyelocytic leukaemia. Curr Top Microbiol Immunol 220:81–112
  PubMed CAS Google Scholar
• Melnick A, Fruchtman S, Zelent A, Liu M, Huang Q, Boczkowska B et al (1999) Identification of novel chromosomal rearrangements in acute myelogenous leukemia involving loci on chromosome 2p23, 15q22 and 17q21. Leukemia 13:1534–1538
  PubMed CAS Google Scholar
• Melnick A, Licht JD (1999) Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 93:3167–3215
  PubMed CAS Google Scholar
• Salomoni P, Pandolfi PP (2002) The role of PML in tumor suppression. Cell 108:165–170
  PubMed CAS Google Scholar
• Reymond A, Meroni G, Fantozzi A, Merla G, Cairo S, Luzi L et al (2001) The tripartite motif family identifies cell compartments. EMBO J 20:2140–2151
  PubMed CAS Google Scholar
• Deshaies RJ, Joazeiro CA (2009) RING domain E3 ubiquitin ligases. Annu Rev Biochem 78:399–434
  PubMed CAS Google Scholar
• Meroni G, Diez-Roux G (2005) TRIM/RBCC, a novel class of ‘single protein RING finger’ E3 ubiquitin ligases. Bioessays 27:1147–1157
  PubMed CAS Google Scholar
• Burkhard P, Stetefeld J, Strelkov SV (2001) Coiled coils: a highly versatile protein folding motif. Trends Cell Biol 11:82–88
  PubMed CAS Google Scholar
• Borden KL, Boddy MN, Lally J, O'Reilly NJ, Martin S, Howe K et al (1995) The solution structure of the RING finger domain from the acute promyelocytic leukaemia proto-oncoprotein PML. EMBO J 14:1532–1541
  PubMed CAS Google Scholar
• Borden KL, Lally JM, Martin SR, O'Reilly NJ, Solomon E, Freemont PS (1996) In vivo and in vitro characterization of the B1 and B2 zinc-binding domains from the acute promyelocytic leukemia protooncoprotein PML. Proc Natl Acad Sci U S A 93:1601–1606
  PubMed CAS Google Scholar
• Fagioli M, Alcalay M, Tomassoni L, Ferrucci PF, Mencarelli A, Riganelli D et al (1998) Cooperation between the RING + B1-B2 and coiled-coil domains of PML is necessary for its effects on cell survival. Oncogene 16:2905–2913
  PubMed CAS Google Scholar
• Condemine W, Takahashi Y, Zhu J, Puvion-Dutilleul F, Guegan S, Janin A et al (2006) Characterization of endogenous human promyelocytic leukemia isoforms. Cancer Res 66:6192–6198
  PubMed CAS Google Scholar
• Fagioli M, Alcalay M, Pandolfi PP, Venturini L, Mencarelli A, Simeone A et al (1992) Alternative splicing of PML transcripts predicts coexpression of several carboxy-terminally different protein isoforms. Oncogene 7:1083–1091
  PubMed CAS Google Scholar
• Jensen K, Shiels C, Freemont PS (2001) PML protein isoforms and the RBCC/TRIM motif. Oncogene 20:7223–7233
  PubMed CAS Google Scholar
• Nisole S, Stoye JP, Saib A (2005) TRIM family proteins: retroviral restriction and antiviral defence. Nat Rev Microbiol 3:799–808
  PubMed CAS Google Scholar
• Lin HK, Bergmann S, Pandolfi PP (2004) Cytoplasmic PML function in TGF-beta signalling. Nature 431:205–211
  PubMed CAS Google Scholar
• Salomoni P, Bellodi C (2007) New insights into the cytoplasmic function of PML. Histol Histopathol 22:937–946
  PubMed CAS Google Scholar
• Condemine W, Takahashi Y, Le Bras M, de The H (2007) A nucleolar targeting signal in PML-I addresses PML to nucleolar caps in stressed or senescent cells. J Cell Sci 120:3219–3227
  PubMed CAS Google Scholar
• Bischof O, Kirsh O, Pearson M, Itahana K, Pelicci PG, Dejean A (2002) Deconstructing PML-induced premature senescence. EMBO J 21:3358–3369
  PubMed CAS Google Scholar
• Guo A, Salomoni P, Luo J, Shih A, Zhong S, Gu W et al (2000) The function of PML in p53-dependent apoptosis. Nat Cell Biol 2:730–736
  PubMed CAS Google Scholar
• Borden KL (2002) Pondering the promyelocytic leukemia protein (PML) puzzle: possible functions for PML nuclear bodies. Mol Cell Biol 22:5259–5269
  PubMed CAS Google Scholar
• Chang KS, Fan YH, Andreeff M, Liu J, Mu ZM (1995) The PML gene encodes a phosphoprotein associated with the nuclear matrix. Blood 85:3646–3653
  PubMed CAS Google Scholar
• Duprez E, Saurin AJ, Desterro JM, Lallemand-Breitenbach V, Howe K, Boddy MN et al (1999) SUMO-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear localisation. J Cell Sci 112(Pt 3):381–393
  PubMed CAS Google Scholar
• Bernardi R, Scaglioni PP, Bergmann S, Horn HF, Vousden KH, Pandolfi PP (2004) PML regulates p53 stability by sequestering Mdm2 to the nucleolus. Nat Cell Biol 6:665–672
  PubMed CAS Google Scholar
• Yang S, Kuo C, Bisi JE, Kim MK (2002) PML-dependent apoptosis after DNA damage is regulated by the checkpoint kinase hCds1/Chk2. Nat Cell Biol 4:865–870
  PubMed CAS Google Scholar
• Ishov AM, Sotnikov AG, Negorev D, Vladimirova OV, Neff N, Kamitani T et al (1999) PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J Cell Biol 147:221–234
  PubMed CAS Google Scholar
• Zhong S, Salomoni P, Pandolfi PP (2000) The transcriptional role of PML and the nuclear body. Nat Cell Biol 2:E85–E90
  PubMed CAS Google Scholar
• Stuurman N, de Graaf A, Floore A, Josso A, Humbel B, de Jong L et al (1992) A monoclonal antibody recognizing nuclear matrix-associated nuclear bodies. J Cell Sci 101(Pt 4):773–784
  PubMed Google Scholar
• Dellaire G, Bazett-Jones DP (2004) PML nuclear bodies: dynamic sensors of DNA damage and cellular stress. Bioessays 26:963–977
  PubMed CAS Google Scholar
• Boisvert FM, Hendzel MJ, Bazett-Jones DP (2000) Promyelocytic leukemia (PML) nuclear bodies are protein structures that do not accumulate RNA. J Cell Biol 148:283–292
  PubMed CAS Google Scholar
• Eskiw CH, Dellaire G, Bazett-Jones DP (2004) Chromatin contributes to structural integrity of promyelocytic leukemia bodies through a SUMO-1-independent mechanism. J Biol Chem 279:9577–9585
  PubMed CAS Google Scholar
• Wang J, Shiels C, Sasieni P, Wu PJ, Islam SA, Freemont PS et al (2004) Promyelocytic leukemia nuclear bodies associate with transcriptionally active genomic regions. J Cell Biol 164:515–526
  PubMed CAS Google Scholar
• Kumar PP, Bischof O, Purbey PK, Notani D, Urlaub H, Dejean A et al (2007) Functional interaction between PML and SATB1 regulates chromatin-loop architecture and transcription of the MHC class I locus. Nat Cell Biol 9:45–56
  PubMed Google Scholar
• Shiels C, Islam SA, Vatcheva R, Sasieni P, Sternberg MJ, Freemont PS et al (2001) PML bodies associate specifically with the MHC gene cluster in interphase nuclei. J Cell Sci 114:3705–3716
  PubMed CAS Google Scholar
• Ayaydin F, Dasso M (2004) Distinct in vivo dynamics of vertebrate SUMO paralogues. Mol Biol Cell 15:5208–5218
  PubMed CAS Google Scholar
• Fu C, Ahmed K, Ding H, Ding X, Lan J, Yang Z et al (2005) Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3. Oncogene 24:5401–5413
  PubMed CAS Google Scholar
• Kamitani T, Nguyen HP, Kito K, Fukuda-Kamitani T, Yeh ET (1998) Covalent modification of PML by the sentrin family of ubiquitin-like proteins. J Biol Chem 273:3117–3120
  PubMed CAS Google Scholar
• Soignet SL, Maslak P, Wang ZG, Jhanwar S, Calleja E, Dardashti LJ et al (1998) Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N Engl J Med 339:1341–1348
  PubMed CAS Google Scholar
• Zhu J, Lallemand-Breitenbach V, de The H (2001) Pathways of retinoic acid- or arsenic trioxide-induced PML/RARalpha catabolism, role of oncogene degradation in disease remission. Oncogene 20:7257–7265
  PubMed CAS Google Scholar
• Jeanne M, Lallemand-Breitenbach V, Ferhi O, Koken M, Le Bras M, Duffort S et al (2010) PML/RARA oxidation and arsenic binding initiate the antileukemia response of As2O3. Cancer Cell 18:88–98
  PubMed CAS Google Scholar
• Lallemand-Breitenbach V, de The H (2010) PML nuclear bodies. Cold Spring Harb Perspect Biol 2:a000661
  PubMed Google Scholar
• Aoto T, Saitoh N, Ichimura T, Niwa H, Nakao M (2006) Nuclear and chromatin reorganization in the MHC-Oct3/4 locus at developmental phases of embryonic stem cell differentiation. Dev Biol 298:354–367
  PubMed CAS Google Scholar
• Flenghi L, Fagioli M, Tomassoni L, Pileri S, Gambacorta M, Pacini R et al (1995) Characterization of a new monoclonal antibody (PG-M3) directed against the aminoterminal portion of the PML gene product: immunocytochemical evidence for high expression of PML proteins on activated macrophages, endothelial cells, and epithelia. Blood 85:1871–1880
  PubMed CAS Google Scholar
• Gambacorta M, Flenghi L, Fagioli M, Pileri S, Leoncini L, Bigerna B et al (1996) Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissues. Am J Pathol 149:2023–2035
  PubMed CAS Google Scholar
• Terris B, Baldin V, Dubois S, Degott C, Flejou JF, Henin D et al (1995) PML nuclear bodies are general targets for inflammation and cell proliferation. Cancer Res 55:1590–1597
  PubMed CAS Google Scholar
• Li W, Ferguson BJ, Khaled WT, Tevendale M, Stingl J, Poli V et al (2009) PML depletion disrupts normal mammary gland development and skews the composition of the mammary luminal cell progenitor pool. Proc Natl Acad Sci U S A 106(12):4725–4730
  PubMed CAS Google Scholar
• Everett RD, Chelbi-Alix MK (2007) PML and PML nuclear bodies: implications in antiviral defence. Biochimie 89:819–830
  PubMed CAS Google Scholar
• Stadler M, Chelbi-Alix MK, Koken MH, Venturini L, Lee C, Saib A et al (1995) Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element. Oncogene 11:2565–2573
  PubMed CAS Google Scholar
• Ferbeyre G, de Stanchina E, Querido E, Baptiste N, Prives C, Lowe SW (2000) PML is induced by oncogenic ras and promotes premature senescence. Genes Dev 14:2015–2027
  PubMed CAS Google Scholar
• Pearson M, Carbone R, Sebastiani C, Cioce M, Fagioli M, Saito S et al (2000) PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature 406:207–210
  PubMed CAS Google Scholar
• de Stanchina E, Querido E, Narita M, Davuluri RV, Pandolfi PP, Ferbeyre G et al (2004) PML is a direct p53 target that modulates p53 effector functions. Mol Cell 13:523–535
  PubMed Google Scholar
• Jiang WQ, Zhong ZH, Henson JD, Reddel RR (2007) Identification of candidate alternative lengthening of telomeres genes by methionine restriction and RNA interference. Oncogene 26:4635–4647
  PubMed CAS Google Scholar
• Stagno D’Alcontres M, Mendez-Bermudez A, Foxon JL, Royle NJ, Salomoni P (2007) Lack of TRF2 in ALT cells causes PML-dependent p53 activation and loss of telomeric DNA. J Cell Biol 179:855–867
  PubMed Google Scholar
• Goldberg AD, Banaszynski LA, Noh KM, Lewis PW, Elsaesser SJ, Stadler S et al (2010) Distinct factors control histone variant H3.3 localization at specific genomic regions. Cell 140:678–691
  PubMed CAS Google Scholar
• Lewis PW, Elsaesser SJ, Noh KM, Stadler SC, Allis CD (2010) Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres. Proc Natl Acad Sci U S A 107:14075–14080
  PubMed CAS Google Scholar
• Seeler JS, Marchio A, Sitterlin D, Transy C, Dejean A (1998) Interaction of SP100 with HP1 proteins: a link between the promyelocytic leukemia-associated nuclear bodies and the chromatin compartment. Proc Natl Acad Sci U S A 95:7316–7321
  PubMed CAS Google Scholar
• He D, Mu ZM, Le X, Hsieh JT, Pong RC, Chung LW et al (1997) Adenovirus-mediated expression of PML suppresses growth and tumorigenicity of prostate cancer cells. Cancer Res 57:1868–1872
  PubMed CAS Google Scholar
• Le XF, Yang P, Chang KS (1996) Analysis of the growth and transformation suppressor domains of promyelocytic leukemia gene, PML. J Biol Chem 271:130–135
  PubMed CAS Google Scholar
• Mu ZM, Le XF, Vallian S, Glassman AB, Chang KS (1997) Stable overexpression of PML alters regulation of cell cycle progression in HeLa cells. Carcinogenesis 18:2063–2069
  PubMed CAS Google Scholar
• Le XF, Vallian S, Mu ZM, Hung MC, Chang KS (1998) Recombinant PML adenovirus suppresses growth and tumorigenicity of human breast cancer cells by inducing G1 cell cycle arrest and apoptosis. Oncogene 16:1839–1849
  PubMed CAS Google Scholar
• Alcalay M, Tomassoni L, Colombo E, Stoldt S, Grignani F, Fagioli M et al (1998) The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein. Mol Cell Biol 18:1084–1093
  PubMed CAS Google Scholar
• Campisi J, d’Adda di Fagagna F (2007) Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 8:729–740
  PubMed CAS Google Scholar
• Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW (1997) Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88:593–602
  PubMed CAS Google Scholar
• Regad T, Bellodi C, Nicotera P, Salomoni P (2009) The tumor suppressor Pml regulates cell fate in the developing neocortex. Nat Neurosci 12:132–140
  PubMed CAS Google Scholar
• Bernardi R, Pandolfi PP (2003) Role of PML and the PML-nuclear body in the control of programmed cell death. Oncogene 22:9048–9057
  PubMed CAS Google Scholar
• Takahashi Y, Lallemand-Breitenbach V, Zhu J, de The H (2004) PML nuclear bodies and apoptosis. Oncogene 23:2819–2824
  PubMed CAS Google Scholar
• Trotman LC, Alimonti A, Scaglioni PP, Koutcher JA, Cordon-Cardo C, Pandolfi PP (2006) Identification of a tumour suppressor network opposing nuclear Akt function. Nature 441:523–527
  PubMed CAS Google Scholar
• Wang ZG, Ruggero D, Ronchetti S, Zhong S, Gaboli M, Rivi R et al (1998) PML is essential for multiple apoptotic pathways. Nat Genet 20:266–272
  PubMed CAS Google Scholar
• Quignon F, De Bels F, Koken M, Feunteun J, Ameisen JC, de The H (1998) PML induces a novel caspase-independent death process. Nat Genet 20:259–265
  PubMed CAS Google Scholar
• Fogal V, Gostissa M, Sandy P, Zacchi P, Sternsdorf T, Jensen K et al (2000) Regulation of p53 activity in nuclear bodies by a specific PML isoform. EMBO J 19:6185–6195
  PubMed CAS Google Scholar
• Salomoni P, Khelifi AF (2006) Daxx: death or survival protein? Trends Cell Biol 16:97–104
  PubMed CAS Google Scholar
• Khelifi AF, D’Alcontres MS, Salomoni P (2005) Daxx is required for stress-induced cell death and JNK activation. Cell Death Differ 12:724–733
  PubMed CAS Google Scholar
• Gurrieri C, Capodieci P, Bernardi R, Scaglioni PP, Nafa K, Rush LJ et al (2004) Loss of the tumor suppressor PML in human cancers of multiple histologic origins. J Natl Cancer Inst 96:269–279
  PubMed CAS Google Scholar
• Lee HE, Jee CD, Kim MA, Lee HS, Lee YM, Lee BL et al (2007) Loss of promyelocytic leukemia protein in human gastric cancers. Cancer Lett 247:103–109
  PubMed CAS Google Scholar
• Zhang P, Chin W, Chow LT, Chan AS, Yim AP, Leung SF et al (2000) Lack of expression for the suppressor PML in human small cell lung carcinoma. Int J Cancer 85:599–605
  PubMed CAS Google Scholar
• Koken MH, Linares-Cruz G, Quignon F, Viron A, Chelbi-Alix MK, Sobczak-Thepot J et al (1995) The PML growth-suppressor has an altered expression in human oncogenesis. Oncogene 10:1315–1324
  PubMed CAS Google Scholar
• Yoon GS, Yu E (2001) Overexpression of promyelocytic leukemia protein and alteration of PML nuclear bodies in early stage of hepatocarcinogenesis. J Korean Med Sci 16:433–438
  PubMed CAS Google Scholar
• Gray PA, Fu H, Luo P, Zhao Q, Yu J, Ferrari A et al (2004) Mouse brain organization revealed through direct genome-scale TF expression analysis. Science 306:2255–2257
  PubMed CAS Google Scholar
• Ito K, Bernardi R, Morotti A, Matsuoka S, Saglio G, Ikeda Y et al (2008) PML targeting eradicates quiescent leukaemia-initiating cells. Nature 453(7198):1072–1078
  PubMed CAS Google Scholar
• Woulfe J, Gray D, Prichett-Pejic W, Munoz DG, Chretien M (2004) Intranuclear rodlets in the substantia nigra: interactions with marinesco bodies, ubiquitin, and promyelocytic leukemia protein. J Neuropathol Exp Neurol 63:1200–1207
  PubMed CAS Google Scholar
• Woulfe JM, Prichett-Pejic W, Rippstein P, Munoz DG (2007) Promyelocytic leukaemia-immunoreactive neuronal intranuclear rodlets in the human brain. Neuropathol Appl Neurobiol 33:56–66
  PubMed CAS Google Scholar
• Villagra NT, Navascues J, Casafont I, Val-Bernal JF, Lafarga M, Berciano MT (2006) The PML-nuclear inclusion of human supraoptic neurons: a new compartment with SUMO-1- and ubiquitin-proteasome-associated domains. Neurobiol Dis 21:181–193
  PubMed CAS Google Scholar
• Villagra NT, Berciano J, Altable M, Navascues J, Casafont I, Lafarga M et al (2004) PML bodies in reactive sensory ganglion neurons of the Guillain-Barre syndrome. Neurobiol Dis 16:158–168
  PubMed CAS Google Scholar
• Berube NG, Mangelsdorf M, Jagla M, Vanderluit J, Garrick D, Gibbons RJ et al (2005) The chromatin-remodeling protein ATRX is critical for neuronal survival during corticogenesis. J Clin Invest 115:258–267
  PubMed CAS Google Scholar
• Ritchie K, Seah C, Moulin J, Isaac C, Dick F, Berube NG (2008) Loss of ATRX leads to chromosome cohesion and congression defects. J Cell Biol 180:315–324
  PubMed CAS Google Scholar
• Berube NG, Healy J, Medina CF, Wu S, Hodgson T, Jagla M et al (2007) Patient mutations alter ATRX targeting to PML nuclear bodies. Eur J Hum Genet 16(2):192–201
  PubMed Google Scholar
• Salomoni P (2009) Stemming out of a new PML era? Cell Death Differ 16:1083–1092
  PubMed CAS Google Scholar
• Milyavsky M, Gan OI, Trottier M, Komosa M, Tabach O, Notta F et al (2010) A distinctive DNA damage response in human hematopoietic stem cells reveals an apoptosis-independent role for p53 in self-renewal. Cell Stem Cell 7:186–197
  PubMed CAS Google Scholar
• Schwamborn JC, Berezikov E, Knoblich JA (2009) The TRIM-NHL protein TRIM32 activates microRNAs and prevents self-renewal in mouse neural progenitors. Cell 136:913–925
  PubMed CAS Google Scholar
• Tuoc TC, Stoykova A (2008) Trim11 modulates the function of neurogenic transcription factor Pax6 through ubiquitin-proteosome system. Genes Dev 22:1972–1986
  PubMed CAS Google Scholar
• Chai Y, Koppenhafer SL, Shoesmith SJ, Perez MK, Paulson HL (1999) Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro. Hum Mol Genet 8:673–682
  PubMed CAS Google Scholar
• Kaytor MD, Duvick LA, Skinner PJ, Koob MD, Ranum LP, Orr HT (1999) Nuclear localization of the spinocerebellar ataxia type 7 protein, ataxin-7. Hum Mol Genet 8:1657–1664
  PubMed CAS Google Scholar
• Klement IA, Skinner PJ, Kaytor MD, Yi H, Hersch SM, Clark HB et al (1998) Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Cell 95:41–53
  PubMed CAS Google Scholar
• Takahashi J, Fujigasaki H, Iwabuchi K, Bruni AC, Uchihara T, El Hachimi KH et al (2003) PML nuclear bodies and neuronal intranuclear inclusion in polyglutamine diseases. Neurobiol Dis 13:230–237
  PubMed CAS Google Scholar
• Takahashi J, Fujigasaki H, Zander C, El Hachimi KH, Stevanin G, Durr A et al (2002) Two populations of neuronal intranuclear inclusions in SCA7 differ in size and promyelocytic leukaemia protein content. Brain 125:1534–1543
  PubMed Google Scholar
• Yamada M, Sato T, Shimohata T, Hayashi S, Igarashi S, Tsuji S et al (2001) Interaction between neuronal intranuclear inclusions and promyelocytic leukemia protein nuclear and coiled bodies in CAG repeat diseases. Am J Pathol 159:1785–1795
  PubMed CAS Google Scholar
• Mackenzie IR, Baker M, West G, Woulfe J, Qadi N, Gass J et al (2006) A family with tau-negative frontotemporal dementia and neuronal intranuclear inclusions linked to chromosome 17. Brain 129:853–867
  PubMed Google Scholar
• Kumada S, Uchihara T, Hayashi M, Nakamura A, Kikuchi E, Mizutani T et al (2002) Promyelocytic leukemia protein is redistributed during the formation of intranuclear inclusions independent of polyglutamine expansion: an immunohistochemical study on Marinesco bodies. J Neuropathol Exp Neurol 61:984–991
  PubMed CAS Google Scholar
• Imarisio S, Carmichael J, Korolchuk V, Chen CW, Saiki S, Rose C et al (2008) Huntington’s disease: from pathology and genetics to potential therapies. Biochem J 412:191–209
  PubMed CAS Google Scholar
• Scaglioni PP, Yung TM, Cai LF, Erdjument-Bromage H, Kaufman AJ, Singh B et al (2006) A CK2-dependent mechanism for degradation of the PML tumor suppressor. Cell 126:269–283
  PubMed CAS Google Scholar
• Lallemand-Breitenbach V, Zhu J, Puvion F, Koken M, Honore N, Doubeikovsky A et al (2001) Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation. J Exp Med 193:1361–1371
  PubMed CAS Google Scholar
• Zhang XW, Yan XJ, Zhou ZR, Yang FF, Wu ZY, Sun HB et al (2010) Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML. Science 328:240–243
  PubMed CAS Google Scholar
• Lafarga M, Berciano MT, Pena E, Mayo I, Castano JG, Bohmann D et al (2002) Clastosome: a subtype of nuclear body enriched in 19S and 20S proteasomes, ubiquitin, and protein substrates of proteasome. Mol Biol Cell 13:2771–2782
  PubMed CAS Google Scholar
• Janer A, Martin E, Muriel MP, Latouche M, Fujigasaki H, Ruberg M et al (2006) PML clastosomes prevent nuclear accumulation of mutant ataxin-7 and other polyglutamine proteins. J Cell Biol 174:65–76
  PubMed CAS Google Scholar
• Qin Q, Inatome R, Hotta A, Kojima M, Yamamura H, Hirai H et al (2006) A novel GTPase, CRAG, mediates promyelocytic leukemia protein-associated nuclear body formation and degradation of expanded polyglutamine protein. J Cell Biol 172:497–504
  PubMed CAS Google Scholar
• Nucifora FC Jr, Sasaki M, Peters MF, Huang H, Cooper JK, Yamada M et al (2001) Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science 291:2423–2428
  PubMed CAS Google Scholar
• Steffan JS, Kazantsev A, Spasic-Boskovic O, Greenwald M, Zhu YZ, Gohler H et al (2000) The Huntington’s disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc Natl Acad Sci U S A 97:6763–6768
  PubMed CAS Google Scholar
• Hayashi T, Sasaki C, Iwai M, Sato K, Zhang WR, Warita H et al (2001) Induction of PML immunoreactivity in rat brain neurons after transient middle cerebral artery occlusion. Neurol Res 23:772–776
  PubMed CAS Google Scholar
• Wang ZG, Delva L, Gaboli M, Rivi R, Giorgio M, Cordon-Cardo C et al (1998) Role of PML in cell growth and the retinoic acid pathway. Science 279:1547–1551
  PubMed CAS Google Scholar
• Wichterle H, Przedborski S (2010) What can pluripotent stem cells teach us about neurodegenerative diseases? Nat Neurosci 13:800–804
  PubMed CAS Google Scholar
• Pardal R, Ortega-Saenz P, Duran R, Lopez-Barneo J (2007) Glia-like stem cells sustain physiologic neurogenesis in the adult mammalian carotid body. Cell 131:364–377
  PubMed CAS Google Scholar
• Zhu J, Zhou J, Peres L, Riaucoux F, Honore N, Kogan S et al (2005) A sumoylation site in PML/RARA is essential for leukemic transformation. Cancer Cell 7:143–153
  PubMed CAS Google Scholar